Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Palatin Technologies claims new melanocortin receptor ligands

June 30, 2010

GSK-1362885 is safe in healthy volunteers and patients with type 2 diabetes

June 30, 2010

Corcept nears enrollment completion in phase III Corlux trial

June 29, 2010

CHMP recommends approval of Shire's VPRIV for type 1 GD

June 29, 2010

Interim phase II data reported on ENB-0040 in childhood hypophosphatasia

June 29, 2010

Pooled phase III data show efficacy of tesamorelin in HIV-related lipodystrophy

June 29, 2010

Sanofi-aventis and Metabolex enter into licensing agreement for novel antidiabetic

June 28, 2010

FDA advisory committee meeting scheduled to review Contrave NDA

June 28, 2010

Versartis commences phase Ia trial of VRS-859 in type 2 diabetes

June 28, 2010

GSK claims calcium-sensing CaS receptor ligands

June 28, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.